The Week28m
Neoantigen DNA vaccine shows promising results against triple-negative breast cancer in initial study
Treatment with personalised neoantigen DNA vaccines is feasible, says a clinical-trial-based study published in Genome ...
News Medical6h
WHO grants Emergency Use Listing for LC16m8 mpox vaccine
The World Health Organization (WHO) has granted Emergency Use Listing (EUL) for the LC16m8 mpox vaccine, making it the second mpox vaccine to be supported by WHO following the Director-General's ...
HealthDay on MSN7h
Barriers to Widespread Access to Cancer Medications Include Excessive Cost
Barriers to widespread access to cancer treatments include excessive cost and lack of affordability, according to a review ...
Merck says blockbuster cancer drug met main goals in trial of new under-the-skin formulation
Merck & Co. Inc.'s reported positive results Tuesday for a new, easier-to-administer formulation of its blockbuster cancer drug Keytruda. Rahway, N.J.-based Merck (MRK) said a trial of the drug, given ...
News Medical15h
New CAR T-cell therapy shows promise against aggressive HER2+ breast cancer
One-third of HER2-positive (HER2+) tumors express the P95HER2 protein, which associates with an aggressive form of breast ...
COVID-19 virus could attack cancer cells and shrink tumors, new study suggests
A new study published in the Journal of Clinical Investigation found that COVID was linked to cancer regression, which could ...
COVID-19 May Cure Cancer! No, You Didn't Read That Wrong; Here's How
In a breakthrough development, scientists from the US have found that cells activated by severe COVID-19 infection can be ...